MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics, Inc. (CCCC)

|||

Balance Sheets Overview

Current Ratio
544.91%
Quick Ratio
544.91%
Cash Ratio
162.93%
Debt to Asset Ratio
31.20%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities, current
    • Cash and cash equivalents
    • Right-of-use asset
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, net o...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
78,610
61,274
74,603
58,809
Marketable securities, current
175,053
174,397
173,934
133,075
Accounts receivable
1,334
2,883
2,401
6,542
Prepaid expenses and other current assets
7,905
6,817
7,172
8,438
Total current assets
262,902
245,371
258,110
206,864
Marketable securities, non-current
46,786
32,600
48,563
7,875
Property and equipment, net
4,149
4,492
4,744
5,134
Right-of-use asset
37,637
39,090
40,532
41,961
Restricted cash
3,443
3,443
3,443
3,443
Other assets
4,487
3,865
3,683
211
Total assets
359,404
328,861
359,075
265,488
Accounts payable
1,121
773
858
1,333
Accrued expenses and other current liabilities
13,785
9,830
13,314
11,270
Deferred revenue, current
26,661
10,124
12,493
17,126
Operating lease liability, current
6,680
6,522
6,367
6,216
Total current liabilities
48,247
27,249
33,032
35,945
Deferred revenue, net of current
13,714
15,440
15,841
19,888
Operating lease liability, net of current
50,178
51,925
53,615
55,247
Total liabilities
112,139
94,614
102,488
111,080
Common stock, par value of 0.0001 per share 300,000,000 shares authorized as of june30, 2026, and december31, 2025, respectively, and 122,905,756 and 96,914,418 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
12
10
9
7
Additional paid-in capital
1,035,154
998,381
995,221
872,521
Accumulated other comprehensive income
-444
-322
50
87
Accumulated deficit
-787,457
-763,822
-738,693
-718,207
Total stockholders equity
247,265
234,247
256,587
154,408
Total liabilities and stockholders equity
359,404
328,861
359,075
265,488
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities,current$175,053K (28.34%↑ Y/Y)Cash and cashequivalents$78,610K (0.58%↑ Y/Y)Prepaid expenses andother current assets$7,905K (-1.40%↓ Y/Y)Accounts receivable$1,334K (-38.18%↓ Y/Y)Total current assets$262,902K (16.99%↑ Y/Y)Marketable securities,non-current$46,786K (455.72%↑ Y/Y)Right-of-use asset$37,637K (-30.58%↓ Y/Y)Other assets$4,487K (2420.79%↑ Y/Y)Property and equipment,net$4,149K (-25.11%↓ Y/Y)Restricted cash$3,443K (0.00%↑ Y/Y)Total assets$359,404K (21.20%↑ Y/Y)Total liabilities andstockholders equity$359,404K (21.20%↑ Y/Y)Total stockholdersequity$247,265K (42.05%↑ Y/Y)Total liabilities$112,139K (-8.43%↓ Y/Y)Accumulated deficit-$787,457K (-14.78%↓ Y/Y)Accumulated othercomprehensive income-$444K (-1380.00%↓ Y/Y)Additional paid-in capital$1,035,154K (20.35%↑ Y/Y)Operating leaseliability, net of current$50,178K (-11.75%↓ Y/Y)Total currentliabilities$48,247K (8.53%↑ Y/Y)Deferred revenue, net ofcurrent$13,714K (-35.16%↓ Y/Y)Common stock, par valueof 0.0001 per share...$12K (71.43%↑ Y/Y)Deferred revenue,current$26,661K (17.86%↑ Y/Y)Accrued expenses andother current...$13,785K (1.70%↑ Y/Y)Operating leaseliability, current$6,680K (10.12%↑ Y/Y)Accounts payable$1,121K (-49.41%↓ Y/Y)